written by
Laura Lassen

Introducing the Clinigma® Portal

Pharma Industry 1 min read , September 4, 2020

An IT portal facilitating secure and easy collection of trial patient feedback
Patient insights and experiences are critical for pharmaceutical companies to successfully bring new drugs to market. To ease the collection and handling of patient experience data in clinical trials, Clinigma® has developed the Clinigma® Portal as a tool to facilitate secure and easy collection of patient feedback at any stage of the drug development process.

The Clinigma® Portal is developed based on Clinigma’s expertise on interviewing trial patients and in close collaboration with global pharmaceutical clients, contract research organizations (CROs), clinical sites, and trial patients.

Key features of the Clinigma® Portal
-
Easy scheduling of global patient interviews
- Strong protection of sensitive patient data
- Secure handling of adverse events (AEs) process
- Facilitating painless communication between research teams, clients, clinical sites, and trial patients

The IT portal takes advantage of Clinigma®’s large network of qualitative researchers (200+) allowing for interviews to be moderated in more than 70 languages. All qualitative researchers are trained in Good Clinical Practice (GCP) as well as Clinigma®’s standard operating procedures (SOPs) for conducting interviews and will follow the requirements agreed with clients in relation to their clinical trials.

Click here to learn more about the Clinigma® Portal.

#patientengagement #patientexperience #clinicaltrials #patientjourney #regulatorycompliance #patientcentricity #patientvoice #qualitativeresearch #patientfocus
Patient-focused insights - delivered directly to your inbox
Sign up for our newsletter